Revenue
2019
2020
2021
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $0 | $0 |
| Research & development | $455,901 | $240,263 | $0 | $0 | — | — | — |
| Operating expenses | $6.4M | $2.8M | $1.4M | — | $23,824 | $4,870 | $6,000 |
| Operating income | −$6.4M | −$2.8M | −$1.4M | — | — | — | — |
| Net income | −$5.6M | −$2.9M | −$1.7M | — | −$23,824 | −$4,870 | −$6,000 |
| Basic EPSper diluted share | — | -$0.15 | -$0.07 | — | $0.00 | $0.00 | $0.00 |
| Diluted EPSper diluted share | -$0.22 | -$0.15 | -$0.07 | — | $0.00 | $0.00 | $0.00 |